Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Argetsinger, LS

Class:Id	Person:873862
_displayName	Argetsinger, LS
_timestamp	2010-06-08 15:58:26
created	[InstanceEdit:873859] Garapati, P V, 2010-06-08
initial	LS
surname	Argetsinger
(author)	[LiteratureReference:873836] Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity [LiteratureReference:873860] Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity [LiteratureReference:982795] Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase [LiteratureReference:997244] Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta [LiteratureReference:1168836] Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1 [LiteratureReference:1168882] Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling [LiteratureReference:1302713] Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants
[Change default viewing format]

No pathways have been reviewed or authored by Argetsinger, LS (873862)